iHuman Free Cash Flow (FCF) History (IH)
iHuman reported $6.6M in free cash flow for fiscal 2025, a decrease of 5.20% from the previous fiscal year, with a free cash flow margin of 5.75%.
View full iHuman company overviewiHuman free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.6M | −$364,000 | −5.20% | +5.75% |
| 2024 | 2024-12-31 | $7.0M | −$16.3M | −69.98% | +5.54% |
| 2023 | 2023-12-31 | $23.3M | −$3.0M | −11.54% | +16.27% |
| 2022 | 2022-12-31 | $26.4M | $25.4M | +2735.38% | +18.45% |
| 2021 | 2021-12-31 | $930,000 | −$30.8M | −97.07% | +0.63% |
| 2020 | 2020-12-31 | $31.7M | — | — | +38.93% |
iHuman free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $31.7M to $6.6M, a compound annual decline of 26.87%.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review iHuman source filings ↗Community posts
iHuman swings to quarterly loss as revenue and app usage decline
iHuman ($IH) reported second-quarter revenue of RMB173.4 million, down from RMB210.9 million a year earlier, and an operating loss of RMB20.8 million versus an RMB18.3 million operating profit. The net result moved to an RMB17.5 million los ...